Francesco Marampon - Concepedia

Author

Francesco Marampon

Sapienza University of Rome ORCID

Also Known As

F Marampon, F. Marampon, FRANCESCO MARAMPON, Francesco Marampon, Laura Lellis, Marampon F, Marampon, Francesco

240

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Sapienza University of Rome University of L'Aquila Policlinico Umberto I San Salvatore Hospital Bambino Gesù Children's Hospital

About

Francesco Marampon is an author at Sapienza University of Rome specializing in cell biology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	1.6K
2	Health Sciences	8	8	413
3	Engineering	1	1	56
4	Natural Sciences	1	1	15
5	Allergy	1	1	12

Francesco Marampon

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Vitamin D Protects Human Endothelial Cells from H2O2 Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation Lorella Polidoro, G. Properzi, Francesco Marampon, Journal of Cardiovascular Translational Research InflammationReductive StressLipid PeroxidationPhysiologyEndothelial Dysfunction	2012	151
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors Francesco Marampon, Carmela Ciccarelli, Bianca M. Zani Molecular Cancer	2006	145
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells Francesco Marampon, Francesca Megiorni, Simona Camero, Cancer Letters Tumor BiologyGenome InstabilityStem-like PhenotypeGliomaMedicine	2017	99
MEK/ERK inhibitor U0126 affects <i>in vitro</i> and <i>in vivo</i> growth of embryonal rhabdomyosarcoma Francesco Marampon, Gianluca Bossi, Carmela Ciccarelli, Molecular Cancer Therapeutics PathologyCancer BiologyTumor BiologyReceptor Tyrosine KinaseCancer Cell Biology	2009	97
A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases Mario Di Staso, Luigi Zugaro, Giovanni Luca Gravina, European Radiology Radiation TherapyPercutaneous Radiofrequency AblationRadionuclide TherapyBrachytherapyFeasibility Study	2011	95
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy Gianluca Bossi, Francesco Marampon, Revital Maor-Aloni, Cell Cycle Mutant P53Mutant P53 ProteinsSystems BiologyConditional Rna InterferenceOncogenic Agent	2008	91
MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells <i>In vitro</i> and <i>In vivo</i> by Downregulating Growth and DNA Repair Signals Francesco Marampon, Giovanni Luca Gravina, Agnese Di Rocco, Molecular Cancer Therapeutics	2011	84
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population Carmela Ciccarelli, Francesca Vulcano, Luisa Milazzo, Molecular Cancer	2016	82
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay Francesco Marampon, Giovanni Luca Gravina, Bianca M. Zani, International Journal of Oncology High-grade GliomasGliomaTumor BiologyNeuro-oncologyRadiation Medicine	2014	80
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells Carmela Ciccarelli, Francesco Marampon, Arianna Scoglio, Molecular Cancer	2005	76

Page 1